Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in human disease tissue to identify and drug targets linked to genomically defined patient populations. The Company is focused on developing treatments for cancer and immune-mediated diseases and is building a pipeline of gene control medicines. The Company’s drug programs include SY-1425 (retinoic acid receptor alpha (RARa) agonist) and SY-1365 (cyclin-dependent kinase 7 (CDK7) inhibitor)SY-1425 (tamibarotene) is an oralpotent and selective agonist, or activator, of the transcription factor RARaSY-1365 is a small molecule inhibitor of the transcriptional kinase known as CDK7. The Company is using its platform to analyze gene expression programs across additional cancerssolid tumorsinflammatory diseases and other diseases to find optimal points of therapeutic intervention in patients.

Day Range Sell:7.90-8.29

Douyu International Holdings Ltd
DOUYU INTERNATIONAL HOLDINGS LIMITED is a China-based company principally engaged in